We show in rat lung microvessel endothelial cells (RLMVEC) that endocytosis is a critical determinant of activation of mitogen-activated protein kinase (MAPK) and thereby regulates endothelial monolayer integrity. In RLMVEC grown in serum-free medium, we observed that albumin supplementation induced the phosphorylation of p38 MAPK within 30 min, which persisted for up to 2 h. Engagement of the endocytic machinery regulated the activation of p38 MAPK that contributed to endothelial cell proliferation and reduction of apoptosis. We also observed an interaction between the caveolar protein caveolin-1 and p38 MAPK with reciprocal coimmunoprecipitation assays and colocalization using double-label immunofluorescence staining. Knockdown of caveolin-1 expression with small interfering RNA significantly reduced endocytosis and activation of p38 MAPK and interfered with the ability of endothelial cells to form a confluent monolayer. Thus caveolae-mediated endocytosis and concomitant activation of p38 MAPK may help to maintain endothelial monolayer integrity by signaling proliferation and survival of endothelial cells.
THE BASIC FUNCTION of endothelial cells lining the vessel wall is their ability to form a continuous confluent monolayer and serve as a semipermeable barrier (11) . Endothelial cells also have a large number of vesicles comprising 15-20% of cell volume (20) . There is a constitutive process of endocytosis mediated by the internalization of the plasmalemmal invaginations, caveolae (20) . Although caveolar internalization is responsible for transcytosis of albumin and other plasma proteins across the endothelial barrier, endocytosis may also have key functions in cell signaling (4, 5, 7, 25) . In the present study, we investigated the possibility that caveolae-mediated endocytosis is a determinant of endothelial cell proliferation and cell survival and thus regulates the integrity of the endothelial monolayer.
We have shown (24) that albumin activation of transforming growth factor (TGF)-␤ receptor (T␤R)II stimulates endocytosis in rat lung microvessel endothelial cell (RLMVEC) monolayers. TGF-␤ signaling is triggered by its binding to a heteromeric complex consisting of two transmembrane serine/threonine kinase receptors, type I and type II (T␤RI and T␤RII) (8, 16, 26) . In serum-deprived RLMVEC, we observed that supplementation with albumin induced activation of caveolaemediated endocytosis (11) and subsequent T␤RII signaling that resulted in Smad2 phosphorylation and Smad4 translocation (21, 24) . These studies did not examine the downstream consequences of activation of endocytosis in promoting endothelial cell proliferation and survival.
Mammalian p38 mitogen-activated protein kinase (MAPK) is activated in response to extracellular stimuli such as UV light, heat, osmotic shock, inflammatory cytokines (TNF-␣ and IL-1␤), and growth factors (e.g., colony-stimulating factor-1) (28) . TGF-␤, through activation of TGF-␤-activated protein kinase-1-binding protein mediates p38 MAPK activation, thus linking TGF-␤ signaling to p38 MAPK activation (23, 27) . In the present study, we showed that induction of caveolaemediated endocytosis in endothelial cells resulted in the activation of p38 MAPK enzyme activity and phosphorylation of p38 MAPK. The activation of p38 MAPK activation induced endothelial cell proliferation and reduced apoptosis. Moreover, depletion of caveolin-1 expression with small interfering RNA (siRNA) significantly reduced endocytosis as well as activation of p38 MAPK and resulted in the impairment of proliferation and apoptosis responses in endothelial cells. These results point to a crucial role of p38 MAPK activation occurring as the result of caveolae-mediated endocytosis in regulating endothelial cell proliferation and survival and thereby controlling the integrity of the endothelial monolayer.
Fluorescence measurements. Fluorescence measurements in live cells (RLMVEC) were performed as described previously (24) with a Nikon Eclipse 800 fluorescence microscope equipped with differential interference contrast (DIC). Fluorescence and DIC images were acquired with a charge-coupled device camera (Hamamatsu Photonics, Hamamatsu, Japan) and processed with Metamorph imaging analysis software (Universal Imaging, West Chester PA).
Endocytosis assay. Endocytosis was assayed by the uptake of albumin with FITC-BSA or TRITC-BSA as the tracer (24) . In RLM-VEC treated with the MAPK p38 inhibitor SB-203580 (6, 7, 25) (Calbiochem, San Diego, CA), the drug (1-20 M) was incubated in increasing concentrations in confluent cell monolayers for 4 h at 37°C. Care was taken to avoid exposure to light during the uptake assay. Endocytosis following caveolin-1 siRNA treatment was similarly assayed.
TUNEL assay.
Terminal deoxynucleotidyltransferase nick end labeling (TUNEL) was used to determine the number of cells undergoing apoptosis. RLMVEC monolayers were fixed with 4% formaldehyde in PBS for 30 min and washed with chilled PBS. Cells were treated with terminal transferase together with FITC-dATP and dATP. In controls, no terminal transferase was included. Cells were observed with a FITC filter set and a Nikon E600 fluorescence microscope. Apoptotic nuclei looked fragmented and stained intensely with fluorescein-conjugated substrate. Nonapoptotic cells showed large vesicular nuclei and had regular chromatin staining. Cells (100) were randomly selected in a given microscopic field, and the percentage of apoptotic cells was determined. At least five such microscopic fields were selected from each experimental condition.
Apoptosis and cell survival assay. Cells undergoing apoptosis were stained with the nuclear dye 4Ј,6Ј-diamidino-2-phenylindole (DAPI) Fig. 1 . A: albumin supplementation of serum-deprived endothelial cells promotes monolayer integrity. a: Rat lung microvessel endothelial cells (RLMVEC) grown in serum-deprived conditions (DMEM alone) for 24 h were rounded and showed loss of monolayer integrity. Arrow points to cell rounding before its detachment from the adherent surface. b: Cells grown in the presence of serum were adherent and formed a confluent, cobblestone monolayer. c: Addition of denatured albumin, treated with dithiothreitol bovine serum albumin (DTT BSA), failed to prevent loss of monolayer integrity induced by serum deprivation and rounding of cells (shown by arrows). d: Incubation of RLMVEC with albumin (BSA) induced cell confluence and enhanced monolayer integrity. Scale bar ϭ 2 m. Experiments were repeated 3 times, and results of typical experiments are represented. B: terminal deoxynucleotidyltransferase nick end labeling (TUNEL) staining of endothelial cells. a: RLMVEC grown in the presence of 4% albumin showed reduced or no TUNEL staining. b: Cells grown in serum-free medium without albumin supplementation showed apoptosis as seen by fragmented nuclei (marked with arrowheads). Since apoptotic cells detached from the monolayer, some nuclei appeared out of the focal plane. c: Cells grown in the presence of 4% albumin showing normal nuclear staining with 4Ј,6Ј-diamidino-2-phenylindole (DAPI) nuclear dye. d: Appearance of fragmented nuclei (arrows) in cells grown in the serum-free medium without albumin, indicating apoptosis. e: In serum-starved cells there is 28% apoptosis without albumin supplementation. At 4% (wt/vol) albumin concentration, the apoptotic index is decreased to 8%. Results are means of n ϭ 3, and bars indicate SD. *Significant reduction in apoptosis in the presence of 4% albumin supplementation. and counted in UV images acquired with a Nikon E600 microscope. Apoptotic cells showed nuclei that appeared fragmented and stained brightly with DAPI, whereas normal live cells had nuclei with rounded vesicular morphology that stained lightly with DAPI and showed finely stippled chromosomal threads. In each randomly chosen field of RLMVEC, 100 -200 cells per field were counted. For the cell survival index, a similar assessment using DAPI staining of live cells was used to determine the fraction of live cells. Three experiments were conducted in each condition, and the results are reported as means Ϯ SD.
Fluorescence-activated cell sorting analysis of apoptosis. RLM-VEC were grown in serum-free or DMEM medium supplemented with albumin and various treatments such as taxol, TGF-␤, p38 inhibitor SB-20385, or caveolin-1 siRNA as indicated. After treatment, cells were exposed to trypsin, washed twice in 2% FBS in PBS (pH 7.4), and filtered through a 60-m nylon mesh. Cells were stained with Vybrant Apoptosis Assay Kit no. 5 (Molecular Probes, Eugene, OR), and fluorescence-activated cell sorting (FACS) analysis was performed. Populations of viable, apoptotic, and dead cells were easily distinguished by flow cytometry using the 488-nm line of the Ar laser. Dead cells were labeled with propidium iodide (PI), and the blue fluorescent Hoechst 33342 stain labeled condensed chromatin of apoptotic cells more brightly than the chromatin of normal cells. Before data acquisition, 1 l of PI per milliliter of cell suspension was added on ice, followed by 1 l of Hoechst 33342. Cells were incubated on ice for 2 min, and PI and Hoechst 33342 fluorescence was read at 575 and 480 nm, respectively. For each experimental condition three independent experiments were conducted, and the data are presented as means Ϯ SD.
Immunostaining and confocal microscopy. RLMVEC were fixed with 4% paraformaldehyde and stained with mouse anti-caveolin-1 monoclonal antibody and polyclonal rabbit anti-p38-P MAPK antibody as described previously (24) . Cells were washed with PBSTriton (0.1%) and labeled with Alexa 488 or Alexa 594 secondary antibodies (1:200 in PBS) for 1 h at room temperature, washed, and mounted with Prolong antifade mounting medium (Molecular Probes). Images were collected with a Zeiss LSM 510 META confocal microscope with the pinhole set to achieve 1 Airy unit.
Lysate and membrane-enriched fraction isolation from RLMVEC. Detergent-soluble membrane fractions were isolated from RLMVEC as described previously (24) .
SDS-PAGE and immunoblotting. RLMVEC were grown to confluence in albumin-free or albumin-supplemented medium in 10-cm or six-well dishes. SDS-PAGE, immunoblotting, and signal detection were performed as described previously (24) .
Inhibition of p38 MAPK. RLMVEC were incubated for 4 or 8 h with the p38 MAPK inhibitor SB-203580 (10 -20 M). Confluent cells were grown either in the absence of serum or in medium supplemented with albumin. Hyperosmotic shock was provided with 0.5 M NaCl.
p38 MAPK assay. RLMVEC were grown to confluence in 10-cm culture plates in DMEM supplemented with 10% FBS and antibiotics and then grown for 24 h in either serum-free or FBS-supplemented medium for 24 h. The p38 MAPK assay was carried out as described previously (1) . Briefly, cells were incubated in the presence or absence of albumin or FBS for 1 h or with 0.5 M NaCl for 30 min at 37°C. Cells were then lysed as described previously (24) . Cell lysate was immunoprecipitated with rabbit anti-p38 polyclonal antibody together with protein G-Sepharose. The immunocomplex was subsequently washed with phosphorylation lysis buffer containing 0.1% Triton X-100 and twice with kinase buffer [mM: 25 HEPES, 25 MgCl2, 25 ␣-glycerophosphate, 0.5 ATP, 2 dithiothreitol (DTT), and 0.1 Na3VO4, with 20 g of glutathione S-transferase-ATF-2 fusion protein] for 20 min at 30°C. Proteins were analyzed by SDS-PAGE, and the phosphorylated protein substrate was detected by immunoblotting with anti-phospho-ATF-2 antibody diluted 1:100 in PBS. The blot from the kinase assay was stripped and probed with an antibody against p38 MAPK to normalize protein loading. We similarly studied the induction of p38 MAPK phosphorylation after treatment of RLM-VEC with TGF-␤. Cells were incubated with the optimum dose of 2 ng/ml TGF-␤ (R&D Systems, Minneapolis, MN) for different time periods. Cell lysates were prepared, and protein fractions were immunoblotted with antibodies against p38-P MAPK. The blots were stripped and reblotted with rabbit anti-p38 MAPK as described above.
CFSE dye dilution assay and FACS analysis. RLMVEC were grown to confluence in 10-cm dishes in DMEM supplemented with 10% FBS and antibiotics. Confluent monolayers were incubated in serum-free medium for 24 h. In one group 100 g/ml albuminsupplemented DMEM was used, whereas in the other group RLM-VEC were maintained in albumin-free medium. Cells were detached with trypsin, suspended and washed with chilled PBS twice, and stained with 5 g/ml of CFSE dye on ice for 10 min. At the concentration of CFSE dye used, cytotoxic effects were not observed. The cell-permeant fluorescein-based dye attaches to cytoplasmic components of the cells, resulting in uniform brightness. On cell division, the dye is distributed equally between daughter cells, allowing the resolution of up to eight cycles of cell divisions by flow cytometry (10, 15) . Cells were suspended at a final concentration of 5 ϫ 10 7 cells/ml, washed with DMEM three times to remove nonspecific binding of the dye, and analyzed with a Beckman cell sorter. FITClabeled beads were used to calibrate the input. Samples from the cells were collected on day 0 from albumin-free and albumin-supplemented cultures. The stained cells were activated by incubating in medium containing albumin and grown at 37°C in the dark. RLMVEC proliferation was checked in cells grown in the presence of the p38 MAPK inhibitor SB-203580 at concentrations of 10 and 20 g/ml. In indicated experiments, cells were treated with 2 mM taxol or transfected with caveolin-1-specific siRNA or control siRNA (see Knockdown of caveolin-1 expression by siRNA) and starved for 24 h after 2 days of siRNA transfection. In one group of cells transfected with caveolin-1 siRNA albumin was supplemented in serum-free medium for 24 h, whereas the other group of cells were simply grown in serum-free medium. After 24 h, the CFSE fluorescence was measured and analyzed with a Beckman Coulter counter (Chaska, MN).
Coimmunoprecipitation of caveolin-1 and p38 MAPK. Immunoprecipitation and Western blotting were used to determine the molecular association between p38 MAPK and caveolin-1. Cell lysate preparation from RLMVEC, immunoprecipitation, Western blotting, and signal detection were carried out as described previously (24) . About 250 l of the total cell lysate containing an equal amount of total Rat lung microvessel endothelial cell (RLMVEC) cultures were grown in serum-free medium (SF). After 48 h, the cells were grown in serum-freemedium for 24 h and supplemented with 4% bovine serum albumin (BSA), 10% serum, or no supplementation. Cell death was assessed with terminal deoxynucleotidyltransferase nick end labeling (TUNEL) staining and fluorescence-activated cell sorting (FACS) as described in METHODS. Survival index, fraction of live cells per 100 cells in the field; TGF-␤, transforming growth factor-␤.
protein was incubated with 4 g of rabbit polyclonal anti-p38 MAPK antibody. The immunoprecipitated proteins were separated by SDS-PAGE and Western blotted with anti-caveolin-1 antibody. In the first set of experiments, rabbit polyclonal affinity-purified anti-caveolin-1 antibody (sc-894, Santa Cruz Biotechnology) was used. Control rabbit IgG resulted in negative staining, whereas the anti-p38 MAPK antibody (sc-535) stained a band of 38 kDa. In controls, control IgG rabbit or primary antibody preadsorbed with the antigenic peptide did not stain the protein band corresponding to p38 MAPK. Experiments were also performed in reverse in which anti-p38 MAPK (sc-535) antibody was used for immunoprecipitation and anti-caveolin-1 antibody was used for Western blotting. When specific peptides were used to block the primary anti-caveolin-1 antibody, no staining was observed by immunoblot, indicating the specificity of the affinity-purified primary antibodies. The experiments were repeated three times and gave similar results.
Knockdown of caveolin-1 expression by siRNA. RLMVEC were grown to confluence on gelatin-coated cover glass and placed in six-well culture plates in 10% FBS-supplemented DMEM. The target sequences for caveolin-1 (GenBank accession no. BC009685) doublestranded (ds)RNA correspond to the 21 nucleotides 403-423 (AA-GAGCTTCCTGATTGAGATT) of the coding sequence of human caveolin-1 (2). We determined by a BLAST search that this 21-nucleotide sequence is completely conserved in the human, mouse, and rat caveolin-1 genes. Cells were treated with either siRNA specific for caveolin-1 or sham siRNA with scrambled sequence that was checked with the NCBI Blast program. dsRNA corresponding to the caveolin-1 and sham dsRNA were purchased from Dharmacon (Lafayette, CO) and used according to the manufacturer's instructions. RLMVEC were seeded at a density of 5 ϫ 10 4 cells on gelatin-coated glass coverslips 24 h before siRNA transfection. For each well, 200 l of serum-free DMEM was mixed with 5 l of Neophectin (Deerfield, IL) liposome-based transfection reagent and incubated at room temperature (RT) for 10 min. To this mixture, caveolin-1-specific or sham dsRNA was added and incubated for 10 min at RT. Cells were washed with 1 ml of serum-free medium and incubated with 30 ng of dsRNA or only the Neophectin-containing medium. Complete serum-containing medium (800 l) was added to each well, and cells were incubated at 37°C in a humidified 5% CO 2 chamber for 24 or 48 h. Downregulation of caveolin-1 expression was ascertained by both Western blotting and immunostaining using caveolin-1-specific antibody. The experiments were repeated three times and gave reproducible results. Figure 1Aa shows that RLMVEC grown in minimal medium (DMEM) in the absence of serum and other growth factors for 24 h lose their integrity as a monolayer, begin to detach from the surface, and show signs of cell degeneration. Cells also assumed a rounded phenotype (see arrow pointing to a cell beginning to detach, Fig. 1Aa ). In contrast, cells grown in DMEM in the presence of 10% normal serum grew in a monolayer of typical cobblestone pattern that did not show gaps, cell rounding, or detachment (Fig. 1Ab) . When serum-deprived cells were supplemented with physiological concentrations of albumin (BSA), the monolayer showed the same phenotype as cells grown in the presence of serum (Fig. 1Ad) . Denatured albumin (treated with 50 mM reducing agent DTT) for 1 h and made free of DTT by dialysis of denatured DTT-albumin with three changes of 1 liter of PBS, failed to preserve RLMVEC monolayer integrity (Fig.  1Ac) . We further tested the effects of denaturation of albumin by boiling albumin solution for 10 min, which also failed to preserve monolayer integrity of RLMVEC in serum-free medium (data not shown). There was no significant difference in Fig. 3 . A: Transforming growth factor (TGF)-␤ induces p38 MAPK phosphorylation. Time course of p38 MAPK phosphorylation induced with 2 ng/ml TGF-␤ in RLMVEC grown in albumin-free medium as described in METHODS is shown. Cell lysates were prepared from each group of cells, and 60 g protein was subjected to SDS-PAGE, Western blotted, and probed with rabbit polyclonal antibody raised against phosphorylated form of p38 MAPK (p38-P). p38-P-specific band was detected with secondary antibodies [goat antirabbit IgG conjugated with horseradish peroxidase (HRP)]. To correct for protein loading, blots were stripped and reprobed with polyclonal rabbit anti-p38 antibody. Experiments were repeated 3 times, and results of typical experiments are represented. B: densitometry plot depicting p38 MAPK phosphorylation. Amount of p38-P increased within 15 min of TGF-␤ incubation and returned to basal level within 2 h. The experiment was repeated 3 times. Bars indicate SD. C: albumin supplementation induces p38 MAPK phosphorylation. RLMVEC were grown in albumin-free or albumin-supplemented medium as described in METHODS. Cell lysates were prepared from each group of cells, and 50 g protein was subjected to SDS-PAGE, Western blotted, and probed with rabbit polyclonal antibody raised against p38-P. p38-P-specific band was detected with secondary antibodies (goat anti-rabbit IgG conjugated with HRP). For the protein amount control, the Western blot was stripped and reprobed with anti-p38 antibody (bottom). Experiments were repeated 3 times, and results of typical experiments are represented. D: densitometry of p38 MAPK phosphorylation. Amount of p38-P increased within 15 min of albumin addition and returned to basal level within 2 h. The experiment was repeated 3 times. Bars indicate SD. E: p38 MAPK activity. RLMVEC monolayers were grown and divided into 4 groups. In the 1st group, cells were grown in DMEM supplemented with 10% FBS. In the 2nd group, cells were grown in serum-free medium for 24 h. In the 3rd group, cells were grown in serum-free medium for 24 h and then supplemented with 100 g/ml albumin for 1 h. In the 4th group, cells were grown in serum-free medium for 24 h and supplemented with 0.5 M NaCl for 30 min. Cells without albumin supplementation had low level of p38 kinase activity. Albumin (BSA) or FBS induced p38 MAPK activation. NaCl (0.5 M) was used as a positive control to induce p38 MAPK activation. These experiments were repeated 3 times. ATF-2-P, phospho-activating transcription factor-2.
RESULTS

Activation of endocytosis prevents loss of endothelial monolayer integrity.
the ability of recombinant human albumin, human serum albumin, or rat serum albumin (data not shown) to preserve monolayer integrity. We found that, in contrast, bovine immunoglobulin (10 -200 g/ml) or ovalbumin (100 g/ml) could not be substituted for albumin (data not shown).
We used TUNEL staining (Fig. 1B, a and b) and DAPI staining (Fig. 1B, c and d) to determine the number of cells undergoing apoptosis in RLMVEC monolayers grown in serum-free medium. We observed that supplementing serum-free medium with albumin reduced endothelial apoptosis (Fig. 1B) . The percentage of cells undergoing apoptosis decreased from 22 Ϯ 6% in the absence of albumin to 8 Ϯ 4% in the presence of 4% (wt/vol) albumin, which is the physiological level (Fig.  1Be) . There was no significant difference when BSA or rat serum albumin was substituted in these experiments (data not shown). These results were further confirmed by using FACS and TUNEL staining analyses to determine apoptosis. Results showed that albumin supplementation of serum-free medium reduced apoptosis and increased cell survival ( Table 1) .
Addition of albumin to serum-deprived endothelial cells promotes cell proliferation in a p38 MAPK-dependent manner.
To quantify the ability of albumin to promote cell proliferation, we used the CFSE dye-based dilution assay. This nontoxic cell-permeant fluorescein dye attaches to cytoplasmic components of cells, resulting in uniform brightness. On cell division, the dye is distributed equally (and thus diluted) between daughter cells, allowing resolution of up to eight cell cycles of cell division (15) . Figure 2A shows fluorescence micrographs of RLMVEC stained with CFSE at days 0, 1, and 2 in RLMVEC grown in DMEM alone ( Fig. 2A, a-c) , after supplementation with 0.01% (100 g/ml) albumin ( Fig. 2A, d-f) , and after albumin supplementation of cells treated with the p38 MAPK inhibitor SB-203580 ( Fig. 2A, g-i) . In contrast to serum-deprived cells grown in absence of albumin, cells grown in albumin-supplemented medium showed marked dilution of the dye within 2 days (Fig. 2A, d-f) indicative of cell proliferation. Arrows in Fig. 2A , e and f, indicate dilution of CFSE dye from day 0 to day 2 and formation of a confluent monolayer (Fig. 2Af) , i.e., dilution of CFSE dye in albumin-supplemented cells was greater than in cells grown in albumin-free medium ( Fig. 2A, a-c) . Asterisks in Fig. 2Ac mark intercellular gaps that formed in endothelial monolayers. CFSE dilution similar to that seen in the absence of albumin supplementation was observed when albumin-supplemented RLMVEC were incubated in the presence of the p38 MAPK inhibitor SB-203580 (3, 6, 12) (Fig. 2A, g-i) ; gaps formed in endothelial monolayers treated with SB-203580 even on day 0 after 2 h of treatment (Fig. 2Ag) and were also evident on days 1 and 2 (asterisks, Fig. 2A, h and i) . To address the possibility that CFSE dye could leak out of cells if cell proliferation is blocked, we used the microtubule-binding antiproliferative agent taxol (50 M). In the taxol-treated cells, CFSE dye did not dilute (data not shown), suggesting that inhibition of proliferation resulted in an absence of dye dilution.
We further used flow cytometry to measure cell proliferation in the presence and absence of albumin. Confluent cell monolayers were exposed to serum-free medium for 24 h. In one group 100 g/ml albumin was supplemented, whereas in the other group RLMVEC were grown in albumin-free medium. Cells were detached with trypsin, suspended and washed twice with chilled PBS, and stained with 5 g/ml of CFSE dye. Figure 2B shows the FACS profile of RLMVEC grown in the presence and absence of 0.01% albumin. The x-axis shows the fluorescence intensity in log units, and the y-axis shows the number of cells. The continuous thin line shows CFSE dye fluorescence at day 0 in cells grown in DMEM, and the thick line shows the cells supplemented with albumin at day 0. The thin dotted line shows CFSE dye distribution at day 1 in cells grown in DMEM, and the thick dotted line shows CFSE dye in cells supplemented with albumin on day 1. There was a greater shift (indicative of dye dilution) toward lower fluorescence intensity in cells grown in the presence of albumin compared with cells grown in DMEM alone. We examined the effects of taxol on RLMVEC survival and apoptosis with FACS analysis in serum-deprived conditions and when cells were supplemented with albumin. Taxol (2 mM) showed an increase in apoptosis in serum-deprived cells, whereas cells supplemented with albumin showed reduced apoptosis (Table 1) . No significant increase in apoptosis in RLMVEC was observed when taxol was included in the medium at lower concentrations (100 M to 1 mM) compared with cells grown in serum-free medium for 24 h (Table 1) .
p38 MAPK inhibitor induces endothelial cell survival. To determine the role of p38 MAPK in RLMVEC survival and induction of apoptosis, we preincubated RLMVEC in serumfree medium or medium supplemented with 4% albumin with the p38 MAPK inhibitor SB-203580. Cells were analyzed with FACS and TUNEL staining as described above. Serum-free conditions reduced cell survival and promoted apoptosis, whereas addition of albumin improved cell survival (Table 1) . SB-203580 slightly reduced the effects of serum deprivation on cell death. However, SB-203580 did not significantly alter the effect of albumin in promoting cell survival and reducing apoptosis in serum-deprived cells (Table 1) .
TGF-␤ and albumin supplementation induce p38 MAPK phosphorylation. We previously demonstrated (24) that engagement of endocytic machinery results in T␤RII-activated signaling. Therefore, we investigated whether the T␤RII ligand TGF-␤ induces the phosphorylation of p38 MAPK in RLM-VEC. Figure 3 , A and B, shows activation of p38 MAPK phosphorylation as the result of treating RLMVEC with 2 ng/ml TGF-␤; p38 MAPK phosphorylation increased within 30 Fig. 4 . Coimmunoprecipitation (IP) of caveolin-1 (Cav-1) and p38-MAPK. A: cell lysates were prepared from RLMVEC as described in METHODS, and 250 l of the total cell lysate was incubated with 4 g of rabbit polyclonal anti-Cav-1 antibody. The precipitated proteins were run on 10% SDS-PAGE gels and immunoblotted (IB) with rabbit polyclonal anti-p38 MAPK antibody. Goat-anti-rabbit IgG antibody conjugated with HRP (diluted 1:2,000 in PBS) was used to detect the primary antibodies. In control experiments, precipitation was carried out with protein G-Sepharose beads alone or with a rabbit preimmune serum in place of the anti-Cav-1 antibody. B: in a reciprocal experiment, 300 l of total cell lysate was incubated with 5 g of rabbit polyclonal anti-p38 MAPK antibody. The immunoprecipitated proteins were run on a SDS-PAGE and immunoblotted as described in A, except that in the primary antibody incubation blots were incubated with rabbit polyclonal anti-Cav-1 antibody. Goat-anti-rabbit IgG antibody conjugated with HRP (diluted 1:2,000 in PBS) was used to detect the primary antibody. In control experiments, precipitation was done with protein G-Sepharose beads alone or with a rabbit preimmune serum in place of anti-p38 MAPK antibody. These experiments were repeated 3 times. min and returned to the basal level within 120 min. We further examined the effect of TGF-␤ on RLMVEC cell survival by FACS analysis and TUNEL staining. RLMVEC treated with 1 ng of TGF-␤ for 24 h in both serum-free medium and in medium supplemented with 4% albumin showed reduced apoptosis compared with serum-deprived RLMVEC (Table 1) .
Since the p38 MAPK inhibitor interfered with RLMVEC proliferation and cell survival induced by albumin supplementation (above), we examined the effects of this intervention on p38 MAPK activation. We observed p38 MAPK phosphorylation (p38-P MAPK) induced by albumin supplementation of serum-deprived cells (Fig. 3, C and D) . Phosphorylation increased within 15 min and returned to basal levels within 120 min.
Albumin supplementation induces p38 MAPK activation. To determine whether p38 MAPK kinase was activated, we performed a kinase assay (1). After albumin supplementation for 1 h, cells were lysed and proteins were immunoprecipitated with polyclonal anti-p38 antibody. Glutathione S-transferase-ATF-2 fusion protein was used as a substrate for p38 MAPK (14) . Proteins were analyzed by SDS-PAGE, and phosphorylation was detected by immunoblotting with anti-phospho-ATF-2 antibody. The blot from the kinase assay was stripped and probed with an antibody raised against p38 MAP to normalize for protein loading. Lower basal kinase activity was observed in cells grown in the albumin-free medium. However, serum deprivation of endothelial cells followed by supplementation with albumin increased p38 MAPK kinase activity in a time-dependent manner (Fig. 3E) . In positive control experiments, cells grown in high osmotic conditions (0.5 M NaCl) to induce cell stress or with FBS were also observed to have increased p38 MAPK kinase activity (Fig. 3E) .
Caveolin-1 association with p38 MAPK. Caveolae internalization is responsible for endocytosis induced by albumin (11) . Therefore, to determine the mechanism of p38 MAPK activation, we investigated whether p38 MAPK was associated with caveolin-1, the protein constituent of caveolae. As shown in Fig. 4 , immunoprecipitation of caveolin-1 using polyclonal anti-caveolin-1 antibody and Western blotting with anti-p38 MAPK antibody reveal that the two proteins are associated. In a reciprocal experiment in which cell lysates were immunoprecipitated with anti-p38 MAPK antibody, we detected caveolin-1 by Western blotting (Fig. 4) . As a control, there was absence of caveolin-1 coimmunoprecipitation when normal rabbit IgG was used as the precipitating antibody.
Albumin supplementation induces translocation of p38 MAPK. To determine the distribution of p38 MAPK and caveolin-1 in the serum-deprived condition and in the presence of albumin, we double-stained RLMVEC with a monoclonal antibody specific for caveolin-1 and a rabbit polyclonal antibody against the phosphorylated form of p38 MAPK (p38-P MAPK). Figure 5A shows coimmunostaining of caveolin-1 and p38-P MAPK in 24-h serum-deprived cells. Caveolin-1 was localized in the membrane and perinuclear regions (Fig. 5Aa) . p38-P MAPK was localized mostly in nuclear and perinuclear regions and was less evident in the cytosol (Fig. 5Ab) , with little merging of the two proteins (Fig. 5Ad) . However, in endothelial cells supplemented with albumin, colocalization of caveolin-1 with p38-P MAPK was observed (Fig. 5Bd) .
Caveolin-1 knockdown reduces albumin endocytosis. Immunocytochemical staining of caveolin-1 showed normal punctate staining of caveolin-1 in control cells (Fig. 6Aa) or after sham siRNA treatment (Fig. 6Ab) . However, significant inhibition of caveolin-1 expression was seen in RLMVEC treated with caveolin-1-specific siRNA (Fig. 6Ac) . Western blotting of RLMVEC lysates after treatment with sham siRNA for 48 h showed the 22-kDa protein band stained by anti-caveolin-1 antibody to be unaffected but also that this caveolin-1-specific band was reduced in the caveolin-1 siRNA-treated cells (Fig.  6Ad) . Actin, used to assess protein loading, was approximately the same in all lanes (Fig. 6Ad) . We determined whether inhibition of caveolin-1 affects albumin endocytosis. Figure  6Bb shows that endothelial cells treated with caveolin-1 siRNA for 48 h had a significant reduction in albumin endocytosis compared with RLMVEC treated with sham siRNA ( Figure  6Ba ). We also measured the time course of reduction of albumin endocytosis in RLMVEC treated with caveolin-1 siRNA (Fig. 6Bc) . We observed a 50% reduction of albumin endocytosis in caveolin-1-depleted RLMVEC compared with control cells. Caveolin-1 knockdown of these cells also reduced the expression of caveolin-2, but inhibiting caveolin-2 expression by caveolin-2 siRNA treatment alone had no effect on endocytosis (data not shown).
Caveolin-1 knockdown promotes loss of endothelial monolayer integrity. Endothelial cells treated with caveolin-1 siRNA (in which endocytosis was impaired as shown above) induced the formation of interendothelial gaps and disrupted the endothelial monolayer (Fig. 6Cb) . In control cells treated with sham siRNA for 48 h, the endothelial monolayer remained confluent and normal in appearance (Fig. 6Ca) . 
Caveolin-1 knockdown reduces p38 MAPK phosphorylation.
We examined the effect of reducing caveolin-1 expression on albumin endocytosis-induced phosphorylation of p38 MAPK. RLMVEC were treated with caveolin-1 siRNA as described above and serum deprived for 24 h, and endocytosis was activated with albumin. p38 MAPK phosphorylation was determined by Western blotting after 1 h of albumin endocytosis in caveolin-1 siRNA-and control siRNA-treated cells. Inhibition of caveolin-1 expression by specific siRNA resulted in reduction of the p38 MAPK phosphorylation following albumin endocytosis compared with control cells transfected with sham siRNA (Fig. 7A) . Expression of p38 MAPK in caveolin-1 siRNA-treated cell lysate was not significantly altered (Fig.  7B) . We found reduction in the basal p38-P MAPK level in the caveolin-1 depleted cell lysate (Fig. 7A) . The requirement of caveolin-1 expression in the induction of p38-P MAPK by albumin endocytosis was further examined by immunostaining. RLMVEC with normal caveolin-1 expression and cells in which caveolin-1 expression was reduced by siRNA were stained after albumin endocytosis (Fig. 7, C and D) . Knockdown of caveolin-1 expression resulted in reduced basal expression of p38-P MAPK and inhibition of p38 phosphorylation on albumin supplementation compared with the RLMVEC with normal caveolin-1 expression (Fig. 7C) . RLMVEC were treated with sham small interfering RNA (siRNA) or caveolin-1 (Cav-1) siRNA as described in METHODS. Cultures were grown in serum-free medium (SF). After 48 h, cells were grown in serum-free medium for 24 h and supplemented with 4% BSA, 10% serum, or no supplementation. Cell death was assessed with TUNEL staining and FACS as described in METHODS. Fig. 7 . A: effect of siRNA-mediated Cav-1 knockdown on p38 MAPK phosphorylation. p38-P and Cav-1 Western blot from RLMVEC transfected with Cav-1 siRNA or control siRNA after induction of endocytosis with albumin is shown. As control, total p38 MAPK is shown at bottom. These experiments were repeated 3 times and gave similar results. B: densitometry of p38 MAPK phosphorylation. Induction of p38 MAPK phosphorylation by albumin supplementation in cells treated with control siRNA or with Cav-1 specific siRNA is shown. Inhibition of Cav-1 expression reduced p38 MAPK phosphorylation induced by albumin endocytosis. *Significant inhibition of p38 phosphorylation in RLMVEC treated with Cav-1 siRNA. C: immunostaining of Cav-1 and phospho p38-MAPK in control siRNA-treated RLMVEC induced by albumin endocytosis. Cells were starved in serum-free medium for 24 h (a and b) and treated with 4% albumin for 30 min at 37°C to induce endocytosis (c and d). Treated cells were fixed in formaldehyde, permeabilized with 0.1% Triton, and stained with mouse monoclonal anti-caveolin-1 monoclonal antibody (a) or rabbit anti-phospho-p38 MAPK polyclonal antibody (b) and examined using confocal microscopy. c: nuclear staining with DAPI. d: merged image. Scale bar ϭ 20 m. D: immunostaining of Cav-1 and phospho p38-MAPK in Cav-1 siRNA-treated RLMVEC induced by albumin endocytosis. RLMVEC were treated with Cav-1 siRNA for 48 h on glass coverslips as described. Treated cells were starved in serum-free medium for 24 h and stained as described with mouse anti-caveolin-1 monoclonal antibody (a) or rabbit anti-phospho-p38 MAPK antibody (b). Cav-1 siRNA-treated RLMVEC grown in serum-free medium were induced with endocytosis by supplementing cells with 4% albumin. Cells were stained as described with mouse anti-caveolin-1 monoclonal antibody (c) or rabbit anti-phospho-p38 MAPK antibody (d). Scale bar ϭ 20 m.
Caveolin-1 knockdown reduces cell survival. We investigated whether caveolin-1 expression affects cell survival in serum-starved and albumin-supplemented RLMVEC. Inhibition of caveolin-1 expression by siRNA reduced apoptosis when RLMVEC were grown in serum-free conditions compared with the RLMVEC transfected with control siRNA (Table 2 ). There was a decrease in cell survival when caveolin-1 siRNA-treated cells were grown in serum-free medium or after addition of albumin to activate endocytosis (Table 2) .
DISCUSSION
The endocytic machinery in endothelial cells has multiple functions. It is known that endocytosis enables cells to regulate the surface expression of receptors by targeting them for degradation (4, 5, 7) . Data presented here show another important function of endocytosis as induced by albumin supplementation of endothelial cells grown in serum-free conditions. We showed that activation of endocytosis was essential in regulating the p38 MAPK activity in endothelial cells. We demonstrated an interaction of p38 MAPK with caveolin-1, the principal marker of caveolae (19) . On the basis of these findings, we propose that this interaction is crucial in regulating endothelial cell proliferation and survival and thereby in helping to maintain the integrity of the endothelial monolayer barrier.
Our findings showed that activation of endocytosis by albumin in serum-deprived endothelial cells was involved in reducing apoptosis and promoting proliferation of endothelial cells. The CFSE dye dilution assay (10, 15) and FACS analysis were used to demonstrate that albumin supplementation of endothelial cells resulted in the activation of endocytosis and thereby signaled endothelial cell proliferation. The TUNEL assay showed that endocytosis also reduced endothelial apoptosis and thereby promoted cell survival. Cell proliferation and survival were impaired in the absence of endocytosis induced by albumin supplementation. Native albumin appeared to be essential for the endocytosis response since albumin denaturation rendered it ineffective in activation of normal levels of endocytosis and promoting cell growth and reducing apoptosis. Recombinant albumin also has the same effect as native albumin (data not shown), suggesting that serum-associated constituents of albumin were not responsible for the effect.
We examined the role of the microtubule-stabilizing drug taxol in the presence and absence of albumin supplementation in regulating the endocytosis-induced endothelial cell survival response. In this experiment, albumin addition to the medium increased the survival of taxol-treated endothelial cells. At lower concentrations of the drug between 100 M and 1 mM, no significant apoptosis was observed, whereas taxol induced apoptosis at 2 mM. Importantly, apoptosis was reduced when albumin was supplemented in the taxol-treated cells. These results demonstrate that activation of endocytosis plays a key role in promoting cell survival.
We previously reported (24) that T␤RII-mediated signaling can activate caveolae-mediated endocytosis in endothelial cells. As p38 MAPK activation is downstream of T␤RII activation (9, 27) , we examined the possibility that signaling via the T␤RII-p38 MAPK pathway is a requirement for endocytosis and the consequent endothelial cell growth and survival responses. We found that TGF-␤ induced p38 MAPK phosphorylation and that inhibition of p38 MAPK by SB-203580 blocked endocytosis and interfered with endothelial proliferation and survival. These observations suggest an important role of endocytosis induced by the T␤RII-p38 MAPK signaling pathway in activating endothelial proliferation and reducing endothelial apoptosis. Our results are in agreement with studies showing that p38 MAPK activation is a crucial determinant of cell proliferation (6, 13) .
The mechanism responsible for activation of p38 MAPK following endocytosis is unclear (29, 30) . The knockdown of caveolin-1 expression with siRNA resulted in a reduction in p38 MAPK phosphorylation. This finding suggests that caveolin-1-mediated signaling (22, 25) is involved in regulating p38 MAPK activation. Using high-throughput RNA interference and automated image analysis Pelkmans et al. (18) showed that Src and MAP kinases regulate caveolae-mediated endocytosis. The findings of Pelkmans et al. support our observation that activation of endocytosis regulates p38 MAPK activation and thus may control proliferation and survival of endothelial cells and the integrity of the endothelial monolayer. We observed that p38 MAPK phosphorylation did not last beyond 2 h, suggesting a negative-feedback downregulation of p38 MAPK activity. Other studies have demonstrated that MAPK activation via phosphorylation is also short-lived despite the near constant level of MAPK protein during the course of stimulation (28) .
Our data show an association of p38 MAPK with caveolin-1 in endothelial cells following albumin supplementation of serum-deprived cells, a condition that activates caveolae-mediated endocytosis (11, 17) . This finding raises the possibility that caveolin-1 is involved in p38 MAPK activation during endocytosis. We observed that siRNA-induced knockdown of caveolin-1 reduced endocytosis as well as cell survival. Caveolin-1 association with p38 MAPK secondary to caveolaemediated endocytosis may be involved in p38 MAPK activation and thereby the engagement of endothelial cell proliferation signaling complex. However, the mechanisms responsible for the association of caveolin-1 and p38 MAPK and regulation of p38 MAPK activity remain unclear. As several kinases are inextricably linked to the endocytic machinery (18) , the interaction of caveolin-1 and p38 MAPK may be important in bringing together components of the endocytic machinery and the signaling modules regulating endothelial cell proliferation and apoptosis.
